Neogen Stock EBITDA
| NEOG Stock | USD 11.56 0.04 0.34% |
Neogen fundamentals help investors to digest information that contributes to Neogen's financial success or failures. It also enables traders to predict the movement of Neogen Stock. The fundamental analysis module provides a way to measure Neogen's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Neogen stock.
| Last Reported | Projected for Next Year | ||
| EBITDA | 210 M | 220.5 M |
Neogen | EBITDA |
Neogen Company EBITDA Analysis
Neogen's EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
Current Neogen EBITDA | 182.6 M |
Most of Neogen's fundamental indicators, such as EBITDA, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Neogen is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Neogen EBITDA Driver Correlations
Understanding the fundamental principles of building solid financial models for Neogen is extremely important. It helps to project a fair market value of Neogen Stock properly, considering its historical fundamentals such as EBITDA. Since Neogen's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Neogen's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Neogen's interrelated accounts and indicators.
Click cells to compare fundamentals
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
| Competition |
Neogen Ebitda
Ebitda |
|
According to the company disclosure, Neogen reported earnings before interest,tax, depreciation and amortization of 182.6 M. This is 79.19% lower than that of the Health Care Equipment & Supplies sector and 47.36% lower than that of the Health Care industry. The ebitda for all United States stocks is 95.32% higher than that of the company.
Neogen EBITDA Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Neogen's direct or indirect competition against its EBITDA to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Neogen could also be used in its relative valuation, which is a method of valuing Neogen by comparing valuation metrics of similar companies.Neogen is currently under evaluation in ebitda category among its peers.
Neogen ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Neogen's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Neogen's managers, analysts, and investors.Environmental | Governance | Social |
Neogen Institutional Holders
Institutional Holdings refers to the ownership stake in Neogen that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Neogen's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Neogen's value.| Shares | Dimensional Fund Advisors, Inc. | 2024-09-30 | 5.6 M | T. Rowe Price Investment Management,inc. | 2024-09-30 | 5.6 M | Geode Capital Management, Llc | 2024-09-30 | 5.1 M | King Luther Capital Management Corp | 2024-09-30 | 5.1 M | Morgan Stanley - Brokerage Accounts | 2024-09-30 | 4.7 M | Fred Alger Management, Llc | 2024-09-30 | 4 M | Blair William & Co | 2024-09-30 | 3.8 M | Northern Trust Corp | 2024-09-30 | 3.6 M | Hhg Plc | 2024-09-30 | 3.6 M | Blackrock Inc | 2024-09-30 | 25.5 M | Vanguard Group Inc | 2024-09-30 | 19.7 M |
Neogen Fundamentals
| Return On Equity | -0.0075 | ||||
| Return On Asset | 0.0085 | ||||
| Profit Margin | (0.03) % | ||||
| Operating Margin | 0.03 % | ||||
| Current Valuation | 3.22 B | ||||
| Shares Outstanding | 216.94 M | ||||
| Shares Owned By Insiders | 0.26 % | ||||
| Shares Owned By Institutions | 99.74 % | ||||
| Number Of Shares Shorted | 22.11 M | ||||
| Price To Earning | 13.36 X | ||||
| Price To Book | 0.92 X | ||||
| Price To Sales | 2.76 X | ||||
| Revenue | 924.22 M | ||||
| Gross Profit | 455.96 M | ||||
| EBITDA | 182.6 M | ||||
| Net Income | (9.42 M) | ||||
| Cash And Equivalents | 347.71 M | ||||
| Cash Per Share | 3.22 X | ||||
| Total Debt | 906.24 M | ||||
| Debt To Equity | 0 % | ||||
| Current Ratio | 9.07 X | ||||
| Book Value Per Share | 14.52 X | ||||
| Cash Flow From Operations | 35.26 M | ||||
| Short Ratio | 11.82 X | ||||
| Earnings Per Share | (2.19) X | ||||
| Price To Earnings To Growth | 0.66 X | ||||
| Target Price | 15.75 | ||||
| Number Of Employees | 2.92 K | ||||
| Beta | 1.22 | ||||
| Market Capitalization | 2.52 B | ||||
| Total Asset | 4.55 B | ||||
| Retained Earnings | 555.62 M | ||||
| Working Capital | 434.91 M | ||||
| Current Asset | 250 M | ||||
| Current Liabilities | 28.6 M | ||||
| Net Asset | 4.55 B |
About Neogen Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Neogen's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Neogen using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Neogen based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
| BTC | Bitcoin | |
| TRX | TRON | |
| BNB | Binance Coin | |
| ADA | Cardano | |
| XRP | XRP |
Check out Neogen Piotroski F Score and Neogen Altman Z Score analysis. For more detail on how to invest in Neogen Stock please use our How to Invest in Neogen guide.You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Neogen. If investors know Neogen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Neogen listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.86) | Earnings Share (2.19) | Revenue Per Share | Quarterly Revenue Growth (0.05) | Return On Assets |
The market value of Neogen is measured differently than its book value, which is the value of Neogen that is recorded on the company's balance sheet. Investors also form their own opinion of Neogen's value that differs from its market value or its book value, called intrinsic value, which is Neogen's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Neogen's market value can be influenced by many factors that don't directly affect Neogen's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Neogen's value and its price as these two are different measures arrived at by different means. Investors typically determine if Neogen is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Neogen's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.